BamSEC and AlphaSense Join Forces
Learn More

NAVIDEA BIOPHARM. DL-001

OTC: NO1A:MU    
Share price (10/14/24): $0.05    
Market cap (10/14/24): $4.604 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-A12G 5 pages Certificate of Designation of Series K Preferred Stock of Navidea Biopharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 9 pages Navidea Biopharmaceuticals, Inc. Certificate of Designation of the Preferences, Rights, Limitations and Restrictions of Series J Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 18 pages Navidea Biopharmaceuticals, Inc. Second Amended and Restated By-Laws Effective September 26, 2022 ************
12/34/56
EX-3.3
from 8-K 6 pages Navidea Biopharmaceuticals, Inc. Certificate of Designation of Voting Powers, Preferences, Limitations, Restrictions, and Relative Rights of Series G Redeemable Preferred Stock
12/34/56
EX-3.2
from 8-K 12 pages Navidea Biopharmaceuticals, Inc. Certificate of Designation of Voting Powers, Preferences, Limitations, Restrictions, and Relative Rights of Series F Redeemable Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 6 pages Certificate of Designation of Series H Junior Participating Preferred Stock of Navidea Biopharmaceuticals, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware Series H Junior Participating Preferred Stock
12/34/56
EX-3.1
from 8-K 3 pages Amendment to the Amended and Restated Bylaws of Navidea Biopharmaceuticals, Inc. April 2, 2021
12/34/56
EX-3.1
from 8-K 11 pages Navidea Biopharmaceuticals, Inc. Certificate of Designations, Voting Powers, Preferences, Limitations, Restrictions, and Relative Rights of Series E Redeemable Convertible Preferred Stock
12/34/56
EX-3.2
from 8-K 11 pages Navidea Biopharmaceuticals, Inc. Certificate of Designations, Voting Powers, Preferences, Limitations, Restrictions, and Relative Rights of Series D Redeemable Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Elimination of Navidea Biopharmaceuticals, Inc. * * * * * * * *
12/34/56
EX-3.1
from 8-K 11 pages Navidea Biopharmaceuticals, Inc. Certificate of Designations, Voting Powers, Preferences, Limitations, Restrictions, and Relative Rights of Series C Redeemable Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 10-K ~20 pages Amended and Restated Certificate of Incorporation of Navidea Biopharmaceuticals, Inc
12/34/56
EX-3.1
from 10-K 10 pages Article Two
12/34/56
EX-3.2
from 10-Q 13 pages Navidea Biopharmaceuticals, Inc. ******************* Amended and Restated By-Laws ************ as Amended July 18, 1995, May 30, 1996, July 26, 2007, and November 7, 2013 ************
12/34/56
EX-3.1
from 10-K 22 pages Article Two
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Ownership Merging Neoprobe Name Change, Inc. Into Neoprobe Corporation (Subsidiary Into Parent Pursuant to Section 253 of the General Corporation Law of Delaware) * * * * * * *
12/34/56
EX-3.2
from 8-K 16 pages Neoprobe Corporation ******************* Amended and Restated By-Laws ************ as Amended July 18, 1995, May 30, 1996, and July 26, 2007 ************
12/34/56
EX-3.1
from SB-2 5 pages Article Two
12/34/56
EX-3.1
from 10QSB ~20 pages Articles of Incorporation or Bylaws
12/34/56